• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Theravance Inc. (THRX)

    -NasdaqGS
    16.46 Down 0.13(0.78%) Mar 27, 4:00PM EDT
    |After Hours : 16.46 0.00 (0.00%) Mar 27, 4:33PM EDT
    Add to Portfolio
    Prev Close:16.59
    Open:16.61
    Bid:15.00 x 200
    Ask:21.30 x 300
    1y Target Est:23.86
    Beta:2.58
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:16.21 - 16.82
    52wk Range:10.58 - 31.80
    Volume:400,385
    Avg Vol (3m):994,081
    Market Cap:1.92B
    P/E (ttm):N/A
    EPS (ttm):-1.50
    Div & Yield:1.00 (5.60%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    THRXDown 0.78%1.92B
    AZNUp 0.43%88.51B
    PFEUp 1.08%211.63B

    Key Statistics

    Forward P/E (1 yr):34.29
    P/S (ttm):229.43
    Ex-Dividend Date:10-Mar-15

    Analysts

    Annual EPS Est (Dec-15) :-0.14
    Quarterly EPS Est (Mar-15) :-0.08
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):0.73

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback